Conversion therapy combined with laparoscopic radical hepatectomy in patient with advanced biliary tract cancer: Laennec approach

doi:10.3877/cma.j.issn.1674-6899.2023.01.012

Abstract

Abstract:

Object

To summarize the feasibility and advantages of using radical surgery under laparoscopy in a patient with advanced biliary tract cancer underwent conversion therapy.

Methods

A retrospective analysis of the clinical data about a patient underwent this novel procedure in the Hepatobiliary and Pancreatic Center of the Department of General Surgery, Affiliated Drum Tower Hospital, Medicine School of Nanjing University in Oct. 2022.

Results

The patient with advanced biliary tract cancer underwent conversion therapy, whose tumor was successfully downstaged, and received radical surgery. Less intraoperative bleeding, no postoperative infection, bleeding, biliary fistula and so on. Tumor markers and related imaging examinations showed no abnormalities 2 months after surgery.

Conclusions

It is expected to improve the long-term prognosis of patients with advanced biliary malignancies by applying the concept of conversion therapy combined with Laennec approach minimally invasive endoscopy to enhance the pathological remission rate and surgical resection rate.

Key words: Biliary tract cancer, Conversion therapy, Anatomical hepatectomy, Laennec approach

Ke Su, Yajuan Cao, Jin Peng, Laizhu Zhang, Decai Yu. Conversion therapy combined with laparoscopic radical hepatectomy in patient with advanced biliary tract cancer: Laennec approach[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(01): 49-51.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhqjwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6899.2023.01.012

https://zhqjwkzz.cma-cmc.com.cn/EN/Y2023/V16/I01/49

Figures/Tables 4

References 7

1	中国抗癌协会肝癌专业委员会胆管癌协作组. 原发性肝癌诊疗指南之肝内胆管癌诊疗中国专家共识(2022版)[J]. 中华消化外科杂志，2022, 21(10): 1269-1301.
2	Oh DY, Lee KH, Lee DW, et al. Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study [J]. Lancet Gastroenterol Hepatol, 2022, 7(6): 522-532.
3	Valle JW, Kelley RK, Nervi B, et al. Biliary tract cancer [J]. Lancet, 2021, 397(10272): 428-444.
4	施国明，陆品相，曹军，等. 靶向治疗与免疫治疗时代肝内胆管癌转化治疗的新策略[J]. 上海医学，2022, 45(4): 226-229.
5	Nara S, Esaki M, Ban D, et al. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials [J]. Jpn J Clin Oncol, 2020, 50(12): 1353-1363.
6	Rizzo A, Brandi G. Neoadjuvant therapy for cholangiocarcinoma: a comprehensive literature review [J]. Cancer Treat Res Commun, 2021, 27: 100354.
7	余德才. 肝脏膜性解剖及Laennec入路解剖性肝切除[J/CD]. 中华腔镜外科杂志(电子版), 2019, 12(6)：332-336.

[1]	Jingfeng Liu, Yao Huang, Yongyi Zeng, Jinhua Zeng, Kecan Lin, Shunfeng Luo. Principles for the determination of surgical plane in laparoscopic anatomic hepatectomy [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2019, 13(03): 220-223.
[2]	Yajuan Cao, Binghua Li, Decai Yu. Conversion therapy combined with robot assisted right hemihepatectomy for a patient with hepatocellular carcinoma through Laennec approach [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(02): 116-119.
[3]	Laizhu Zhang, Yang Yue, Yang Liu, Decai Yu. Laparoscopic anatomical segmentectomy via laennec approach with dorsal approach for S4 for early hepatocellular carcinoma [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2022, 15(04): 238-239.
[4]	Yajuan Cao, Laizhu Zhang, Decai Yu. Conversion therapy combined with robot assisted laparoscopic hepatectomy in patients with advanced hepatocellular carcinoma: laennec approach with dorsal approach [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2022, 15(02): 115-116.
[5]	Lu Zhang, Jinglin Wang, Haozhen Ren, Xiaolei Shi. Progress in clinical application of robot assisted hepatectomy [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2021, 14(06): 375-378.
[6]	Yunfei Yuan. Necessity and timing of surgical resection of hepatocellular carcinoma after conversion therapy [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(01): 11-15.
[7]	Cheng Fang, Yong Xia, Feng Shen. Conversion therapy strategies for unresectable intrahepatic cholangiocarcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(06): 537-541.
[8]	Huinian Zhou, Yumin Li. Conversion Therapy for hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(06): 542-547.
[9]	Chenxin Gan, Xing Wang, Yaozhen Pan. Application of three-dimensional reconstruction in conversion resection of advanced primary liver cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(05): 503-507.
[10]	Rui Ma, Tao Li. Value of conversion therapy in treatment of patients with colorectal cancer liver metastasis [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(04): 398-402.
[11]	Zhilei Zhang, Chong Zhang, Li Peng. Conversion therapy for intrahepatic cholangiocarcinoma: report of one case [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(04): 428-430.
[12]	Yefang Lao, Rui He, Rui Zhu, Xiaohui Zhang, Chunrong Zhu. Multidisciplinary diagnosis and treatment of liver metastases from unresectable colon cancer: a case report and literature review [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2022, 11(06): 516-520.
[13]	Dexiang Zhu, Ye Wei, Li Ren, Qinghai Ye, Xiaoying Wang, Yuehong Cui, Tianshu Liu, Bo Zhou, Yi Chen, Mingliang Wang, Shengxiang Rao, Jian Wang, Jianyong Ding, Jianmin Xu, Xinyu Qin. Analysis of treatment strategy after colorectal cancer MDT discussion in Zhongshan Hospital [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2020, 09(03): 236-239.
[14]	Yuan Zong, Jun Zhou, Lin Shen. Current status of pharmacological therapy of advanced cholangiocarcinomas [J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(03): 214-220.
[15]	Jialei Wang, Haifeng Zhou, Wei Yang, Sheng Liu, Haibin Shi, Weizhong Zhou. Establishment of a survival prediction model for patients with obstructive jaundice caused by unresectable biliary tract cancer undergoing interventional therapy [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(02): 169-178.

Please choose a citation manager

Content to export